BidaskClub cut shares of Humana Inc (NYSE:HUM) from a hold rating to a sell rating in a report issued on Monday, July 31st.
A number of other analysts have also recently weighed in on the stock. Deutsche Bank AG initiated coverage on shares of Humana in a report on Wednesday, April 5th. They issued a hold rating and a $216.00 price target on the stock. Zacks Investment Research upgraded shares of Humana from a hold rating to a buy rating and set a $237.00 price target on the stock in a report on Tuesday, April 18th. Citigroup Inc. began coverage on shares of Humana in a research note on Wednesday, June 28th. They issued a buy rating and a $275.00 target price for the company. Evercore ISI reiterated an outperform rating and issued a $240.00 target price on shares of Humana in a research note on Tuesday, April 25th. Finally, Jefferies Group LLC reiterated a hold rating and issued a $230.00 target price (up from $221.00) on shares of Humana in a research note on Thursday, May 4th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have assigned a buy rating to the stock. The company presently has an average rating of Buy and a consensus target price of $243.65.
Shares of Humana (HUM) opened at 249.99 on Monday. The stock has a 50 day moving average of $239.62 and a 200-day moving average of $222.88. The firm has a market capitalization of $36.13 billion, a P/E ratio of 20.57 and a beta of 0.91. Humana has a 52-week low of $163.50 and a 52-week high of $255.27.
Humana (NYSE:HUM) last issued its earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.08 by $0.41. Humana had a net margin of 4.80% and a return on equity of 24.61%. The company had revenue of $13.53 billion for the quarter, compared to analysts’ expectations of $13.61 billion. During the same period in the prior year, the business earned $2.30 EPS. Equities analysts expect that Humana will post $11.55 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “Humana Inc (HUM) Downgraded by BidaskClub” was first reported by Community Financial News and is the property of of Community Financial News. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this piece of content can be read at https://www.com-unik.info/2017/08/12/bidaskclub-downgrades-humana-inc-hum-to-sell-updated.html.
In other Humana news, SVP Brian P. Leclaire sold 4,971 shares of the business’s stock in a transaction dated Wednesday, June 28th. The shares were sold at an average price of $240.00, for a total transaction of $1,193,040.00. Following the sale, the senior vice president now directly owns 14,258 shares in the company, valued at $3,421,920. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Heidi S. Margulis sold 1,500 shares of the company’s stock in a transaction that occurred on Friday, May 26th. The stock was sold at an average price of $231.96, for a total transaction of $347,940.00. Following the sale, the vice president now owns 8,150 shares in the company, valued at $1,890,474. The disclosure for this sale can be found here. 0.80% of the stock is owned by corporate insiders.
Several hedge funds have recently added to or reduced their stakes in the company. Guardian Life Insurance Co. of America raised its stake in Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock worth $119,000 after buying an additional 4 shares during the last quarter. Acrospire Investment Management LLC acquired a new position in shares of Humana during the second quarter worth about $120,000. Independent Portfolio Consultants Inc. increased its position in shares of Humana by 22.1% in the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock worth $125,000 after buying an additional 94 shares during the period. Point72 Asia Hong Kong Ltd acquired a new position in shares of Humana during the first quarter worth about $128,000. Finally, Northwestern Mutual Wealth Management Co. increased its position in shares of Humana by 139.5% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 558 shares of the insurance provider’s stock worth $134,000 after buying an additional 325 shares during the period. Hedge funds and other institutional investors own 99.66% of the company’s stock.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
What are top analysts saying about Humana Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Humana Inc and related companies.